1. Subpart H – Accelerated Approval of New Drugs for Serious or Life-threatening Illnesses;Food and Drug Administration,2017
2. Subpart E – Accelerated Approval of Biological Products for Serious or Life-threatening Illnesses;Food and Drug Administration,2017
3. Guidance for Industry: Expedited Programs for Serious Conditions – Drugs and Biologics;Food and Drug Administration,2014
4. Food and Drug Administration Safety and Innovation Act,2012
5. 21st Century Cures Act,2016